Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
Gürbey Ocak(St. Antonius Ziekenhuis), Kitty J. Jager(Amsterdam University Medical Centers), Patrik Finne(Hospital District of Helsinki and Uusimaa), Maria Stendahl(Region Jönköpings län), Maarten B. Rookmaaker(University Medical Center Utrecht), Halima Resić(University of Sarajevo), Runólfur Pálsson(Reykjavík University), Aleix Cases(Hospital Clínico Universitario de Valencia), F. Jarraya(University of Sfax), Marianne C. Verhaar(Utrecht University), Ziad A. Massy(Inserm), Cécile Couchoud(Agence de la Biomédecine), Marlies Noordzij(University of Amsterdam), Friedo W. Dekker(Leiden University Medical Center), Johan De Meester(AZ Sint-Lucas), Jaap W. Groothoff(University of Amsterdam), Bård Waldum-Grevbo(Oslo University Hospital), James Heaf(Zealand University Hospital)
Cited by 31
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808
When do we need competing risks methods for survival analysis in nephrology?
|Nephrology Dialysis Transplantation|2013|674